Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Ambient air pollution and pulmonary vascular volume on computed tomography: the MESA Air Pollution and Lung cohort studies.

Aaron CP, Hoffman EA, Kawut SM, Austin JHM, Budoff M, Michos ED, Hinckley Stukovsky K, Sack C, Szpiro AA, Watson KD, Kaufman JD, Barr RG.

Eur Respir J. 2019 Jun 5;53(6). pii: 1802116. doi: 10.1183/13993003.02116-2018. Print 2019 Jun.

PMID:
31167881
2.

Association between image-defined risk factors and neuroblastoma outcomes.

Phelps HM, Ndolo JM, Van Arendonk KJ, Chen H, Dietrich HL, Watson KD, Hilmes MA, Chung DH, Lovvorn HN 3rd.

J Pediatr Surg. 2019 Jun;54(6):1184-1191. doi: 10.1016/j.jpedsurg.2019.02.040. Epub 2019 Mar 1.

PMID:
30885556
3.

Clinical, histopathologic, cystoscopic, and fluorescence in situ hybridization analysis of proliferative urethritis in 22 dogs.

Borys MA, Hulsebosch SE, Mohr FC, Watson KD, Sykes JE, Simpson KW, Westropp JL.

J Vet Intern Med. 2019 Jan;33(1):184-191. doi: 10.1111/jvim.15349. Epub 2018 Dec 5.

4.

Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.

Kearsley-Fleet L, Davies R, De Cock D, Watson KD, Lunt M, Buch MH, Isaacs JD, Hyrich KL; BSRBR-RA Contributors Group.

Ann Rheum Dis. 2018 Oct;77(10):1405-1412. doi: 10.1136/annrheumdis-2018-213378. Epub 2018 Jul 6.

5.

Maintaining oncologic integrity with minimally invasive resection of pediatric embryonal tumors.

Phelps HM, Ayers GD, Ndolo JM, Dietrich HL, Watson KD, Hilmes MA, Lovvorn HN 3rd.

Surgery. 2018 Aug;164(2):333-343. doi: 10.1016/j.surg.2018.03.020. Epub 2018 May 8.

PMID:
29751968
6.

Long-term persistence of TNF-inhibitor treatment in patients with psoriatic arthritis. Data from the British Society for Rheumatology Biologics Register.

Fagerli KM, Kearsley-Fleet L, Watson KD, Packham J, Contributors Group BR, Symmons DPM, Hyrich KL.

RMD Open. 2018 Jan 7;4(1):e000596. doi: 10.1136/rmdopen-2017-000596. eCollection 2018.

7.

RNA polymerase III-positive systemic sclerosis in a patient with circumscribed morphea.

Watson KD, Makol A.

Rheumatology (Oxford). 2017 Nov 1;56(11):1856. doi: 10.1093/rheumatology/kex225. No abstract available.

PMID:
29088451
8.

Serious infection risk after 1 year between patients with rheumatoid arthritis treated with rituximab or with a second TNFi after initial TNFi failure: results from The British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.

Silva-Fernández L, De Cock D, Lunt M, Low AS, Watson KD; BSRBR-RA Contributors Group, Symmons DPM, Hyrich KL.

Rheumatology (Oxford). 2018 Sep 1;57(9):1533-1540. doi: 10.1093/rheumatology/kex304.

9.

Mortality in patients with interstitial lung disease treated with rituximab or TNFi as a first biologic.

Druce KL, Iqbal K, Watson KD, Symmons DPM, Hyrich KL, Kelly C.

RMD Open. 2017 Jul 13;3(1):e000473. doi: 10.1136/rmdopen-2017-000473. eCollection 2017.

10.

Was Jack the Ripper a Slaughterman? Human-Animal Violence and the World's Most Infamous Serial Killer.

Knight A, Watson KD.

Animals (Basel). 2017 Apr 10;7(4). pii: E30. doi: 10.3390/ani7040030.

11.

Priming is key to effective incorporation of image-guided thermal ablation into immunotherapy protocols.

Silvestrini MT, Ingham ES, Mahakian LM, Kheirolomoom A, Liu Y, Fite BZ, Tam SM, Tucci ST, Watson KD, Wong AW, Monjazeb AM, Hubbard NE, Murphy WJ, Borowsky AD, Ferrara KW.

JCI Insight. 2017 Mar 23;2(6):e90521. doi: 10.1172/jci.insight.90521.

13.

Pregnancy outcomes in women with rheumatoid arthritis ever treated with rituximab.

De Cock D, Birmingham L, Watson KD, Kearsley-Fleet L; BSRBR Control Centre Consortium, Symmons DP, Hyrich KL.

Rheumatology (Oxford). 2017 Apr 1;56(4):661-663. doi: 10.1093/rheumatology/kew493. No abstract available.

PMID:
28137762
14.

Relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis.

Low AS, Symmons DP, Lunt M, Mercer LK, Gale CP, Watson KD, Dixon WG, Hyrich KL; British Society for Rheumatology Biologics Register for Rheumatoid Arthritis (BSRBR-RA) and the BSRBR Control Centre Consortium.

Ann Rheum Dis. 2017 Apr;76(4):654-660. doi: 10.1136/annrheumdis-2016-209784. Epub 2017 Jan 10.

15.

Feasibility of quantitative contrast ultrasound imaging of bladder tumors in dogs.

Pollard RE, Watson KD, Hu X, Ingham E, Ferrara KW.

Can Vet J. 2017 Jan;58(1):70-72.

16.

Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register.

Saad AA, Ashcroft DM, Watson KD, Symmons DPM, Noyce PR, Hyrich KL; BSRBR.

Rheumatology (Oxford). 2017 Apr 1;56(4):672-673. doi: 10.1093/rheumatology/kew454. No abstract available.

17.

Response to: 'Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor?' by Nocturne et al.

Mercer LK, Galloway JB, Lunt M, Davies R, Low AA, Dixon WG, Watson KD, Symmons DP, Hyrich KL.

Ann Rheum Dis. 2017 Feb;76(2):e4. doi: 10.1136/annrheumdis-2016-210631. Epub 2016 Dec 1. No abstract available.

PMID:
27934677
18.

Use and effectiveness of tocilizumab among patients with rheumatoid arthritis: an observational study from the British Society for Rheumatology Biologics Register for rheumatoid arthritis.

Kihara M, Davies R, Kearsley-Fleet L, Watson KD, Lunt M, Symmons DP, Hyrich KL; British Society for Rheumatology Biologics Register.

Clin Rheumatol. 2017 Feb;36(2):241-250. doi: 10.1007/s10067-016-3485-5. Epub 2016 Dec 2.

19.

Effectiveness and safety of TNF inhibitors in adults with juvenile idiopathic arthritis.

Kearsley-Fleet L, McErlane F, Foster HE, Lunt M, Watson KD, Symmons DP, Hyrich KL.

RMD Open. 2016 Oct 7;2(2):e000273. eCollection 2016.

20.

The incidence of cancer in patients with rheumatoid arthritis and a prior malignancy who receive TNF inhibitors or rituximab: results from the British Society for Rheumatology Biologics Register-Rheumatoid Arthritis.

Silva-Fernández L, Lunt M, Kearsley-Fleet L, Watson KD, Dixon WG, Symmons DP, Hyrich KL; British Society for Rheumatology Biologics Register (BSRBR) Control Centre Consortium.

Rheumatology (Oxford). 2016 Nov;55(11):2033-2039. Epub 2016 Aug 22.

21.

Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.

Mercer LK, Galloway JB, Lunt M, Davies R, Low AL, Dixon WG, Watson KD; BSRBR Control Centre Consortium, Symmons DP, Hyrich KL.

Ann Rheum Dis. 2017 Mar;76(3):497-503. doi: 10.1136/annrheumdis-2016-209389. Epub 2016 Aug 8.

22.

Isotretinoin for acne and rosacea.

Watson KD, Miest RY, Tollefson MM.

Semin Cutan Med Surg. 2016 Jun;35(2):79-86. doi: 10.12788/j.sder.2016.023.

PMID:
27416313
23.

Enrofloxacin enhances the effects of chemotherapy in canine osteosarcoma cells with mutant and wild-type p53.

York D, Withers SS, Watson KD, Seo KW, Rebhun RB.

Vet Comp Oncol. 2017 Sep;15(3):1087-1100. doi: 10.1111/vco.12250. Epub 2016 Jun 23.

24.

Risk of Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis treated with inhibitors of tumour necrosis factor α: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.

Bruce ES, Kearsley-Fleet L, Watson KD, Symmons DP, Hyrich KL.

Rheumatology (Oxford). 2016 Jul;55(7):1336-7. doi: 10.1093/rheumatology/kew200. Epub 2016 Apr 26. No abstract available.

PMID:
27118877
25.

Syntheses and Biological Evaluations of Highly Functionalized Hydroxamate Containing and N-Methylthio Monobactams as Anti-Tuberculosis and β-Lactamase Inhibitory Agents.

Majewski MW, Watson KD, Cho S, Miller PA, Franzblau SG, Miller MJ.

Medchemcomm. 2016 Jan 1;7(1):141-147. Epub 2015 Oct 5.

26.

Evaluation of optimal water fluoridation on the incidence and skeletal distribution of naturally arising osteosarcoma in pet dogs.

Rebhun RB, Kass PH, Kent MS, Watson KD, Withers SS, Culp WTN, King AM.

Vet Comp Oncol. 2017 Jun;15(2):441-449. doi: 10.1111/vco.12188. Epub 2016 Jan 14.

27.

Association Between Ischemic Stroke and Tumor Necrosis Factor Inhibitor Therapy in Patients With Rheumatoid Arthritis.

Low AS, Lunt M, Mercer LK, Watson KD, Dixon WG, Symmons DP, Hyrich KL.

Arthritis Rheumatol. 2016 Jun;68(6):1337-45. doi: 10.1002/art.39582.

28.

Ultrasound ablation enhances drug accumulation and survival in mammary carcinoma models.

Wong AW, Fite BZ, Liu Y, Kheirolomoom A, Seo JW, Watson KD, Mahakian LM, Tam SM, Zhang H, Foiret J, Borowsky AD, Ferrara KW.

J Clin Invest. 2016 Jan;126(1):99-111. doi: 10.1172/JCI83312. Epub 2015 Nov 23.

29.

Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.

Mercer LK, Lunt M, Low AL, Dixon WG, Watson KD, Symmons DP, Hyrich KL; BSRBR Control Centre Consortium.

Ann Rheum Dis. 2015 Jun;74(6):1087-93. doi: 10.1136/annrheumdis-2013-204851. Epub 2014 Mar 31.

30.

Complete regression of local cancer using temperature-sensitive liposomes combined with ultrasound-mediated hyperthermia.

Kheirolomoom A, Lai CY, Tam SM, Mahakian LM, Ingham ES, Watson KD, Ferrara KW.

J Control Release. 2013 Nov 28;172(1):266-273. doi: 10.1016/j.jconrel.2013.08.019. Epub 2013 Aug 28.

31.

Biologic treatment response among adults with juvenile idiopathic arthritis: results from the British Society for Rheumatology Biologics Register.

McErlane F, Foster HE, Davies R, Lunt M, Watson KD, Symmons DP, Hyrich KL.

Rheumatology (Oxford). 2013 Oct;52(10):1905-13. doi: 10.1093/rheumatology/ket248. Epub 2013 Jul 19.

32.

The risk of gastrointestinal perforations in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the BSRBR-RA.

Závada J, Lunt M, Davies R, Low AS, Mercer LK, Galloway JB, Watson KD, Symmons DP, Hyrich KL; British Society for Rheumatology Biologics Register (BSRBR) Control Centre Consortium.

Ann Rheum Dis. 2014 Jan;73(1):252-5. doi: 10.1136/annrheumdis-2012-203102. Epub 2013 May 5.

PMID:
23644671
33.

New and concise syntheses of the bicyclic oxamazin core using an intramolecular nitroso Diels-Alder reaction and ring-closing olefin metathesis.

Watson KD, Carosso S, Miller MJ.

Org Lett. 2013 Jan 18;15(2):358-61. doi: 10.1021/ol303305u. Epub 2012 Dec 31.

34.

Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population.

Mercer LK, Davies R, Galloway JB, Low A, Lunt M, Dixon WG, Watson KD, Symmons DP, Hyrich KL; British Society for Rheumatology Biologics Register (BSRBR) Control Centre Consortium.

Rheumatology (Oxford). 2013 Jan;52(1):91-8. doi: 10.1093/rheumatology/kes350.

35.

Influence of anti-TNF patient warning regarding avoidance of high risk foods on rates of listeria and salmonella infections in the UK.

Davies R, Dixon WG, Watson KD, Lunt M; BSRBR Control Centre Consortium, Symmons DP, Hyrich KL; BSRBR.

Ann Rheum Dis. 2013 Mar;72(3):461-2. doi: 10.1136/annrheumdis-2012-202228. Epub 2012 Oct 17. No abstract available.

PMID:
23076071
36.

Anti-TNF therapy in women with rheumatoid arthritis with a history of carcinoma in situ of the cervix.

Mercer LK, Low AS, Galloway JB, Watson KD, Lunt M, Symmons DP, Hyrich KL; BSRBR Control Centre Consortium.

Ann Rheum Dis. 2013 Jan;72(1):143-4. doi: 10.1136/annrheumdis-2012-201814. Epub 2012 Jul 26. No abstract available.

PMID:
22843488
37.

Challenges for synthesising data in a network of registries for systemic psoriasis therapies.

Ormerod AD, Augustin M, Baker C, Chosidow O, Cohen AD, Dam TN, Garcia-Doval I, Lecluse LL, Schmitt-Egenolf M, Spuls PI, Watson KD, Naldi L.

Dermatology. 2012;224(3):236-43. doi: 10.1159/000338572. Epub 2012 Jun 1.

PMID:
22678413
38.

Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register.

Galloway JB, Mercer LK, Moseley A, Dixon WG, Ustianowski AP, Helbert M, Watson KD, Lunt M, Hyrich KL, Symmons DP.

Ann Rheum Dis. 2013 Feb;72(2):229-34. doi: 10.1136/annrheumdis-2011-201108. Epub 2012 Apr 24.

39.

Rituximab or a second anti-tumor necrosis factor therapy for rheumatoid arthritis patients who have failed their first anti-tumor necrosis factor therapy? Comparative analysis from the British Society for Rheumatology Biologics Register.

Soliman MM, Hyrich KL, Lunt M, Watson KD, Symmons DP, Ashcroft DM; British Society for Rheumatology Biologics Register.

Arthritis Care Res (Hoboken). 2012 Aug;64(8):1108-15. doi: 10.1002/acr.21663.

40.

Ultrasound increases nanoparticle delivery by reducing intratumoral pressure and increasing transport in epithelial and epithelial-mesenchymal transition tumors.

Watson KD, Lai CY, Qin S, Kruse DE, Lin YC, Seo JW, Cardiff RD, Mahakian LM, Beegle J, Ingham ES, Curry FR, Reed RK, Ferrara KW.

Cancer Res. 2012 Mar 15;72(6):1485-93. doi: 10.1158/0008-5472.CAN-11-3232. Epub 2012 Jan 26.

41.

Systemic mastocytosis complicating pregnancy.

Watson KD, Arendt KW, Watson WJ, Volcheck GW.

Obstet Gynecol. 2012 Feb;119(2 Pt 2):486-9. doi: 10.1097/AOG.0b013e318242d3c5.

PMID:
22270448
42.

The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics Register.

Mercer LK, Green AC, Galloway JB, Davies R, Lunt M, Dixon WG, Watson KD; British Society for Rheumatology Biologics Register Control Centre Consortium, Symmons DP, Hyrich KL; British Society for Rheumatology Biologics Register.

Ann Rheum Dis. 2012 Jun;71(6):869-74. doi: 10.1136/annrheumdis-2011-200622. Epub 2012 Jan 12.

43.

Effectiveness of rituximab in patients with rheumatoid arthritis: observational study from the British Society for Rheumatology Biologics Register.

Soliman MM, Hyrich KL, Lunt M, Watson KD, Symmons DP, Ashcroft DM; British Society for Rheumatology Biologics Register.

J Rheumatol. 2012 Feb;39(2):240-6. doi: 10.3899/jrheum.110610. Epub 2011 Dec 15.

44.

Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register.

Galloway JB, Hyrich KL, Mercer LK, Dixon WG, Ustianowski AP, Helbert M, Watson KD, Lunt M, Symmons DP; BSR Biologics Register.

Ann Rheum Dis. 2011 Oct;70(10):1810-4. doi: 10.1136/ard.2011.152769. Epub 2011 Jul 21.

45.

Venous thrombotic events are not increased in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register.

Davies R, Galloway JB, Watson KD, Lunt M, Symmons DP, Hyrich KL; BSRBR Control Centre Consortium, British Society for Rheumatology Biologics Register.

Ann Rheum Dis. 2011 Oct;70(10):1831-4. doi: 10.1136/ard.2011.153536. Epub 2011 Jul 22.

46.

Decreasing temperature shifts hippocampal function from memory formation to modulation of hibernation bout duration in Syrian hamsters.

Arant RJ, Goo MS, Gill PD, Nguyen Y, Watson KD, Hamilton JS, Horowitz JM, Horwitz BA.

Am J Physiol Regul Integr Comp Physiol. 2011 Aug;301(2):R438-47. doi: 10.1152/ajpregu.00016.2011. Epub 2011 May 11.

47.

Novel ultrasound and DCE-MRI analyses after antiangiogenic treatment with a selective VEGF receptor inhibitor.

Watson KD, Hu X, Lai CY, Lindfors HA, Hu-Lowe DD, Tuthill TA, Shalinsky DR, Ferrara KW.

Ultrasound Med Biol. 2011 Jun;37(6):909-21. doi: 10.1016/j.ultrasmedbio.2011.03.001. Epub 2011 Apr 30.

48.

The risk of serious infections in patients receiving anakinra for rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.

Galloway JB, Hyrich KL, Mercer LK, Dixon WG, Watson KD, Lunt M; BSRBR Control Centre Consortium, Symmons DP; British Society for Rheumatology Biologics Register.

Rheumatology (Oxford). 2011 Jul;50(7):1341-2. doi: 10.1093/rheumatology/ker146. Epub 2011 Apr 12. No abstract available.

PMID:
21489973
49.

Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register.

Verstappen SM, King Y, Watson KD, Symmons DP, Hyrich KL; BSRBR Control Centre Consortium, BSR Biologics Register.

Ann Rheum Dis. 2011 May;70(5):823-6. doi: 10.1136/ard.2010.140822. Epub 2011 Feb 28.

50.

Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.

Soliman MM, Ashcroft DM, Watson KD, Lunt M, Symmons DP, Hyrich KL; British Society for Rheumatology Biologics Register.

Ann Rheum Dis. 2011 Apr;70(4):583-9. doi: 10.1136/ard.2010.139774. Epub 2011 Feb 17.

Supplemental Content

Loading ...
Support Center